Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Lansky AJ, Pietras C, Costa RA, Tsuchiya Y, Brodie BR, Cox DA, Aymong ED, Stuckey TD, Garcia E, Tcheng JE, Mehran R, Negoita M, Fahy M, Cristea E, Turco M, Leon MB, Grines CL, Stone GW. Lansky AJ, et al. Among authors: pietras c. Circulation. 2005 Apr 5;111(13):1611-8. doi: 10.1161/01.CIR.0000160362.55803.40. Circulation. 2005. PMID: 15811868 Clinical Trial.
Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association.
Lansky AJ, Hochman JS, Ward PA, Mintz GS, Fabunmi R, Berger PB, New G, Grines CL, Pietras CG, Kern MJ, Ferrell M, Leon MB, Mehran R, White C, Mieres JH, Moses JW, Stone GW, Jacobs AK; American College of Cardiology Foundation; American Heart Association. Lansky AJ, et al. Among authors: pietras cg. Circulation. 2005 Feb 22;111(7):940-53. doi: 10.1161/01.CIR.0000155337.50423.C9. Epub 2005 Feb 1. Circulation. 2005. PMID: 15687113
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
Tsuchiya Y, Lansky AJ, Costa RA, Mehran R, Pietras C, Shimada Y, Sonoda S, Cristea E, Negoita M, Dangas GD, Moses JW, Leon MB, Fitzgerald PJ, Müller R, Störger H, Hauptmann KE, Grube E. Tsuchiya Y, et al. Among authors: pietras c. Am J Cardiol. 2006 Aug 15;98(4):464-9. doi: 10.1016/j.amjcard.2006.02.054. Epub 2006 Jun 19. Am J Cardiol. 2006. PMID: 16893698 Clinical Trial.
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial.
Lansky AJ, Tsuchiya Y, Brener M, Mehran R, Cristea E, Pietras C, Grines CL, Cox DA, Garcia E, Tcheng JE, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Leon MB, Moses J, Stone GW. Lansky AJ, et al. Among authors: pietras c. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):917-24. doi: 10.1002/ccd.21714. Catheter Cardiovasc Interv. 2008. PMID: 19016469
Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial).
Goto K, Lansky AJ, Ng VG, Pietras C, Nargileci E, Mehran R, Parise H, Feit F, Ohman EM, White HD, Bertrand ME, Desmet W, Hamon M, Stone GW. Goto K, et al. Among authors: pietras c. Am J Cardiol. 2014 Dec 1;114(11):1638-45. doi: 10.1016/j.amjcard.2014.09.003. Epub 2014 Sep 18. Am J Cardiol. 2014. PMID: 25312637 Clinical Trial.
Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
Baumbach A, Mullen M, Brickman AM, Aggarwal SK, Pietras CG, Forrest JK, Hildick-Smith D, Meller SM, Gambone L, den Heijer P, Margolis P, Voros S, Lansky AJ. Baumbach A, et al. EuroIntervention. 2015 May;11(1):75-84. doi: 10.4244/EIJY15M04_01. EuroIntervention. 2015. PMID: 25868876 Free article. Clinical Trial.
A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.
Lansky AJ, Schofer J, Tchetche D, Stella P, Pietras CG, Parise H, Abrams K, Forrest JK, Cleman M, Reinöhl J, Cuisset T, Blackman D, Bolotin G, Spitzer S, Kappert U, Gilard M, Modine T, Hildick-Smith D, Haude M, Margolis P, Brickman AM, Voros S, Baumbach A. Lansky AJ, et al. Eur Heart J. 2015 Aug 14;36(31):2070-2078. doi: 10.1093/eurheartj/ehv191. Epub 2015 May 19. Eur Heart J. 2015. PMID: 25990342
88 results